Doxy-PEP is one of the biggest shifts in bacterial STI prevention in years, and it is easy to hear “a pill after sex” and assume testing matters less. The CDC guidance says the opposite: testing is part of the package.

Here is what the CDC actually says, what the newest research adds, and how to talk about it with a provider or a partner. It is general information, not medical advice.

What doxy-PEP is

Doxy-PEP stands for doxycycline post-exposure prophylaxis. It means taking doxycycline, an antibiotic, after sex to lower the chance of getting certain bacterial infections. In the CDC’s guidance the dose is 200 mg, taken as soon as possible and within 72 hours after oral, vaginal or anal sex, with no more than 200 mg in any 24 hours.

It is not the same thing as HIV PEP, which is a separate course of HIV medicine that a provider starts within 72 hours of a possible HIV exposure. Doxy-PEP is about three bacterial infections: syphilis, chlamydia and gonorrhea.

Who the CDC recommends it for

The CDC recommends that providers counsel gay, bisexual and other men who have sex with men, and transgender women, who have had at least one bacterial STI in the past 12 months, and offer doxy-PEP through shared decision-making. For people in those groups without a recent diagnosis who expect higher-risk sex, it says doxy-PEP can be discussed, though the trials did not directly study that group.

For everyone else, including cisgender women and cisgender heterosexual men, the CDC does not make a recommendation, because the evidence is not strong enough yet. A provider can still use clinical judgment for an individual patient.

Testing is part of the guidance

The CDC does not describe doxy-PEP as a replacement for screening. Its guidelines call for bacterial STI testing at the start and then every 3 to 6 months, at the body sites where exposure happens: nucleic acid amplification tests for gonorrhea and chlamydia, and blood tests for syphilis.

HIV screening continues on the schedule that fits the person’s HIV prevention plan, and the same visits are the place for hepatitis B and C screening and any vaccines a provider recommends. Each visit is also when a provider checks whether doxy-PEP is still the right fit.

What doxy-PEP does not cover

The guidance is limited to those three bacterial infections. It makes no claim about HIV, which is handled through PrEP, PEP and regular testing, and an antibiotic is not designed to act on viral infections such as herpes or HPV. Condoms, vaccines and testing all still do their own jobs.

What the newest research adds

In May 2026, The Lancet Infectious Diseases published a study from Kaiser Permanente Southern California and UC Berkeley. It looked at health records for more than 26,000 men who have sex with men and transgender women who were living with HIV or using HIV prevention medicine.

Doxy-PEP kept lowering chlamydia (by about two-thirds) and syphilis (by more than half), and the protection was still visible more than two years later. Gonorrhea was different. An early drop of more than 40 percent faded to no measurable benefit by 2025, as strains resistant to tetracycline-type antibiotics became more common.

It is an observational study, so it shows an association rather than proving cause, and the authors say prevention should be tailored to each infection while resistance is watched closely. The CDC’s own page says the long-term effects on antimicrobial resistance are not yet known and that it will keep monitoring and update its guidelines as new data arrive.

Why a recent result still matters

On doxy-PEP, the point of testing is the same as always: find an infection early, get treated, and let partners know. The gonorrhea numbers are a good example of why a prevention tool alone is not the whole picture, because how well it works can change over time.

A result is also a snapshot. Our post on what the date on a result tells you explains why a negative describes the day the sample was taken, not the days after.

Questions worth asking your provider

Does the CDC guidance fit my situation? How often should I be tested for each infection while I take it? Which body sites will be swabbed? How does this fit with my PrEP schedule, if I use PrEP? What should I do if I notice a symptom between visits? Doxycycline can also cause side effects such as sun sensitivity and stomach upset, so it is worth asking what to expect.

Sharing your status when you use doxy-PEP

Doxy-PEP does not change how a partner should read a result. “Tested on [date], negative for these infections, next test on [date]” is still the line that does the work. A dated result that comes from a provider, rather than a screenshot, lets the other person see what was tested and when.

Sources

• Doxy PEP for Bacterial STI Prevention, CDC
• CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024, CDC (MMWR Recommendations and Reports, June 2024)
• DoxyPEP protects against some STIs, but effectiveness against gonorrhea diminishes, Kaiser Permanente Southern California research news (study published in The Lancet Infectious Diseases, May 2026)
• Doxy-PEP and resistant gonorrhea, news report on the Lancet Infectious Diseases study, Contagion Live, June 2, 2026
• HIV Testing Overview, HIV.gov (U.S. Department of Health and Human Services)

A result shows up in a portal with one word on it, and you are expected to know what to do next. Most of the time the word is clear. Sometimes it is not, and that is where people end up guessing.

Here is a plain-language guide to the three outcomes you are most likely to see, what each one usually means, and what follow-up to expect. It is general information, not a substitute for the provider who ordered your test.

Negative

Negative means the test did not find the infection it looks for. That is good news, with one caveat: it applies to the day the sample was taken. HIV.gov puts it plainly, saying a negative result does not guarantee that you do not have HIV, it just means the test could not detect the virus, and that you should get tested again after the window period. We cover the timing in the date on the result.

For chlamydia and gonorrhea, the CDC describes nucleic acid amplification tests (NAATs) as the most sensitive tests for detecting chlamydia and the recommended test for it.

Positive

Positive means the test found something, but it is often the start of a short sequence rather than the end of one. For HIV, HIV.gov says a positive result must always be confirmed by additional testing in a health care setting, and that a positive on a screening test needs a follow-up blood test.

Syphilis works the same way. CDC laboratory recommendations explain that relying on a single reactive test can misclassify a patient’s status, which is why two different types of tests are used together. The CDC also notes that one of those types can occasionally react to things other than syphilis, such as other infections, vaccinations or autoimmune conditions, which is exactly why the second test exists.

After a confirmed chlamydia or gonorrhea result and treatment, CDC guidance recommends retesting about three months later to catch any repeat infection.

Inconclusive

Inconclusive means the lab could not give a clear answer. It is not a negative and it is not a positive, and it is not a verdict on you. In the CDC’s HIV laboratory algorithm, for example, an inconclusive outcome is handled by requesting an additional specimen and repeating the algorithm. Other tests have their own rules, so the next step is usually a repeat test or a different test, as your provider directs.

The most useful thing to do with an inconclusive result is ask for a date for the repeat, and ask whether anything should change in the meantime.

Questions worth asking your provider

What exactly was tested? Panels differ from clinic to clinic, so confirm which infections were included. Is this result final, or is a confirmation test coming? When should I test again, given the date of my last exposure? Is there anything I should do before the repeat result is back?

Before you share a result

A result is easiest to share once you understand it. Lead with the date and what it covered, and say what you are waiting on if anything is pending. That one-line version, “tested on [date], negative, retesting on [date],” gives the other person what they need without a screenshot’s guesswork.

Sources

• Understanding Your HIV Test Results, HIV.gov (U.S. Department of Health and Human Services)
• CDC Laboratory Recommendations for Syphilis Testing, United States, 2024, CDC (MMWR Recommendations and Reports, 2024)
• CDC Guidance for Reporting Results from the HIV Laboratory Diagnostic Testing Algorithm, CDC
• Chlamydial Infections, STI Treatment Guidelines, CDC
• Sexually Transmitted Infections Treatment Guidelines, 2021, CDC

Last week we covered why the date on a result matters: a negative result speaks for one day. This is the practical follow-up. If something happened recently, when should you test, and when should you test again?

The short answer is that there is no single number. The gap between an exposure and the point a test can reliably pick it up is called the window period, and it differs by infection and by test type. Here is a timeline you can plan around, built from CDC and HIV.gov guidance.

The first 72 hours

If the exposure involved a possible HIV risk and it was within the last three days, do not wait for a test window. CDC guidance says post-exposure prophylaxis (PEP) should be started as soon as possible, and no later than 72 hours after exposure. An urgent care clinic, emergency department or sexual health clinic can evaluate you the same day.

Around two weeks: chlamydia and gonorrhea

One NHS sexual health service advises waiting about two weeks after sex before testing for chlamydia and gonorrhea. Testing sooner can come back negative simply because there was not yet enough to detect.

Around four weeks and beyond: syphilis and HIV

The same service suggests about four weeks for syphilis and HIV, with a second test at three months in some circumstances. For HIV, the CDC gives ranges by test type: a nucleic acid test can usually detect HIV 10 to 33 days after exposure, a lab antigen/antibody test 18 to 45 days, and an antibody test 23 to 90 days. If you test negative before the window period for your test has passed, the CDC says to get tested again after it.

Syphilis is a good reminder that an early negative is not always the last word. CDC guidelines recommend that people who had sexual contact with someone diagnosed with early syphilis in the previous 90 days be treated presumptively, even if their own test results are negative.

If you took PEP, there is a follow-up schedule

CDC recommendations for people who start PEP include HIV testing at the start, again 4 to 6 weeks after exposure, and a final round 12 weeks after exposure. Your provider will set the exact schedule, and it is worth putting the dates in your calendar before you leave the appointment.

Testing again after treatment

A positive chlamydia or gonorrhea result has its own timeline. CDC guidance says people treated for chlamydia should be retested about three months after treatment, because most repeat infections come from reinfection rather than a treatment that did not work. The CDC also discourages chlamydia testing within four weeks of finishing treatment, since leftover genetic material can cause a false positive.

Telling a partner what the timeline is

A date and a plan is a gentler thing to share than a bare result. Something like: “I tested on [date]. I am testing again on [date] to cover the window period.” It tells the other person what your result covers, and it shows you are taking the gap seriously without making it a big moment.

Sources

• Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV: CDC Recommendations, United States, 2025, CDC (MMWR Recommendations and Reports, 2025)
• Getting Tested for HIV, CDC
• HIV Testing Overview, HIV.gov (U.S. Department of Health and Human Services)
• How long should I wait before I test?, Sexual Health Oxfordshire (NHS)
• Syphilis, STI Treatment Guidelines, CDC
• Chlamydial Infections, STI Treatment Guidelines, CDC

A result that says negative feels like a complete answer. It is not quite one, because negative is a statement about a particular day, and the date next to it is doing most of the work.

The short version: a result is only as useful as its date, and the date only means something alongside what has happened since. Here is how to read both, and what to ask for when someone shares a result with you.

Related: How to Prove You’re STD-Free covers what counts as proof beyond the date.

What a test date actually tells you

A test can only find what is detectable on the day it is taken. The gap between getting an infection and the point a test can reliably pick it up is called the window period, and it differs by infection and by type of test.

HIV is the best documented example. HIV.gov puts the window period for HIV tests anywhere from 10 to 90 days, depending on the test. The CDC lists nucleic acid tests at 10 to 33 days, lab antigen/antibody tests at 18 to 45 days, and antibody tests at 23 to 90 days.

For other infections the timing is shorter but still real. One NHS sexual health service advises waiting about two weeks after sex before testing for chlamydia and gonorrhea, and about four weeks for syphilis.

Why the date alone is not the whole story

Take a result dated three weeks ago. On its own it looks reassuring. But if the person tested two days after meeting someone new, it may have been too early to pick up anything from that encounter. And if they have been with other people since, the result says nothing about those at all.

HIV.gov is direct about this: if you have had a possible exposure during the window period, you need to test again after it, even if your first test was negative.

None of this makes a negative result meaningless. It means a result has two edges: how soon after any exposure it was taken, and how much has happened since.

Two questions that make a result useful

When was it taken, and what has happened since? You want the date of the test itself, not the date someone sent it to you. Then ask the second half gently: “Mine was on [date] and I have not been with anyone since. How about yours?”

What did it cover? Panels differ from one clinic to the next, so it is fair to ask which infections were included. “Did yours include HIV and syphilis, or just the standard swabs?” works as a casual question.

If the first ask is the hard part, here are scripts for asking a hookup, situationship, or new partner for test results.

Why the date is the weakest part of a screenshot

A screenshot shows a date, but it cannot show where that date came from. It could be the day the person tested, the day they logged in, or the day they took the picture. A date can be cropped out, and an older result can be passed along as if it were new. Most of the time none of that is deliberate. It is just how screenshots work.

When a result comes straight from the provider, the collection date and result date come from the provider’s record, not from whoever is sending it. We went through the other differences in what a real result has that a screenshot doesn’t.

How recent is recent enough?

There is no single expiration date on a negative result. How often to test depends on the person and their situation, which is why CDC guidance is organized by infection and risk profile. Our STI testing frequency guide walks through those recommendations.

A useful habit is to test on a schedule that fits your life, and to test again after a new partner, ideally with the window period in mind.

If you are the one sharing

Lead with the date. “Tested on [date], negative, no new partners since” gives the other person everything they need in one line, and it makes you the easy one to trust.

Frequently asked questions

What does the date on an STI test result mean? A negative is a statement about a particular day. A test can only find what is detectable on the day it is taken, and the gap between getting an infection and the point a test can reliably pick it up is called the window period.

How long is the HIV window period? HIV.gov puts the window period for HIV tests anywhere from 10 to 90 days, depending on the test. The CDC lists nucleic acid tests at 10 to 33 days, lab antigen/antibody tests at 18 to 45 days, and antibody tests at 23 to 90 days.

What should I ask when someone shares a result with me? Ask when it was taken and what has happened since, using the date of the test itself and not the date it was sent. Then ask what it covered, since panels differ from one clinic to the next.

Does a negative STI result expire? There is no single expiration date on a negative result. How often to test depends on the person and their situation, which is why CDC guidance is organized by infection and risk profile.

Sources

• HIV Testing Overview, HIV.gov (U.S. Department of Health and Human Services)
• HIV Testing, CDC
• How long should I wait before I test?, Sexual Health Oxfordshire (NHS)

The fifth edition of the Hologic Global Women’s Health Index came out this March, and one number in it is hard to look away from: only 10% of women surveyed said they had been tested for an STI in the past year. That is down slightly from the Index’s first year of tracking, meaning the number has not meaningfully moved in five years of measurement. Not up. Not down in a way anyone would call progress. Just stuck.

That is not a story about women not caring about their health. It is a story about a system that has made testing feel optional, awkward, or simply beside the point, right up until it very much is not.

Why the Number Is Stuck

There is not one single reason 90% of women are not getting tested annually. It is a stack of smaller reasons that add up. Doctors often do not bring it up unless a patient asks first, and a lot of patients assume that if it mattered, their provider would have mentioned it. Annual physicals frequently do not include STI screening by default, especially for women who are not pregnant or not presenting symptoms. And the conversation itself, the one where you tell a doctor or a partner you would like to get tested, still carries a weight it should not, because testing has long been coded as something you do when something is wrong rather than something you do because your body deserves routine attention.

New guidance from King County Public Health, published this January, points at part of the fix. Rather than treating STI screening as a once-a-year box to check regardless of circumstances, the guidelines set a baseline of at least annual testing for sexually active people, then recommend more frequent testing, every three to six months, for anyone with risk factors that make a longer gap less useful. Those factors include things like a recent STI diagnosis, more than ten partners in the past year, or inconsistent barrier use. It is a more realistic model than a flat annual reminder, because sexual health does not move on a calendar. It moves based on what is actually happening in someone’s life.

The Missing Piece Is the Conversation, Not the Test

Testing itself has gotten easier over the past decade. Clinics are more accessible, at-home kits exist, insurance coverage has broadened in a lot of places. The bottleneck is not really access anymore, in most cases. It is the conversation around it: deciding to go, telling a partner why, and then, afterward, actually sharing the result with the people who need to know it.

That last step is where a lot of good intentions quietly stall out. Someone gets tested, gets a negative result, and then the information just sits in a patient portal or a paper printout that never makes it into an actual conversation with a partner. Not because anyone is hiding anything, but because there is no easy, low-stakes way to share it. Sending a screenshot feels either like overkill or like proof no one asked for. Saying “I got tested, I’m negative” out loud works, but it puts the whole weight of trust on the listener with nothing to verify it against.

This is the exact gap Protecht was built to close. A verified result, connected securely from participating labs, shareable with a partner in a few taps, no screenshot, no paper trail, no awkward follow-up questions about when exactly “recently” was. The testing part still happens the same way it always has, at a clinic, through a provider. What changes is what happens after: the sharing gets as easy as the testing should have been all along.

Moving the Number

If the 10% figure is going to actually move, and not just get reported on again next spring with the same disappointing footnote, it is going to take more than encouraging people to test. People need a reason that feels immediate, not abstract. Making the results genuinely useful, shareable, and easy to act on gives testing a payoff beyond a number on a portal nobody checks.

Routine testing paired with routine, low-friction sharing is what actually closes gaps like this one. Not another awareness campaign asking people to care more. They already do. What is missing is the infrastructure to make that care count for something the next time it matters, in a conversation with a partner who deserves real information instead of a guess.

Sources

• 1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates — Hologic Global Women’s Health Index, 5th edition, released March 17, 2026. Reports 10% of women surveyed had been tested for an STI in the past year, down 1 percentage point from Year 1 of the Index.
  * 2026 HIV and STI Screening Guidelines — King County Public Health, published January 2026. Recommends at least annual STI screening for sexually active individuals, with more frequent testing (every 3-6 months) for those with risk factors including partner count, recent diagnosis, or inconsistent barrier use.